Your browser doesn't support javascript.
loading
Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.
Morschhauser, Franck; Dahiya, Saurabh; Palomba, M Lia; Martin Garcia-Sancho, Alejandro; Reguera Ortega, Juan Luis; Kuruvilla, John; Jäger, Ulrich; Cartron, Guillaume; Izutsu, Koji; Dreyling, Martin; Kahl, Brad; Ghesquieres, Hervé; Ardeshna, Kirit; Goto, Hideki; Barbui, Anna Maria; Abramson, Jeremy S; Borchmann, Peter; Fleury, Isabelle; Mielke, Stephan; Skarbnik, Alan; de Vos, Sven; Kamdar, Manali; Karmali, Reem; Viardot, Andreas; Farazi, Thalia; Fasan, Omotayo; Lymp, James; Vedal, Min; Nishii, Rina; Avilion, Ariel; Papuga, Jessica; Kumar, Jinender; Nastoupil, Loretta J.
Afiliación
  • Morschhauser F; Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France. franck.morschhauser@chu-lille.fr.
  • Dahiya S; Stanford University School of Medicine, Stanford, CA, USA.
  • Palomba ML; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Martin Garcia-Sancho A; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Reguera Ortega JL; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Kuruvilla J; Hospital Virgen del Rocío, Instituto de Biomedicina de la Universidad de Sevilla, Seville, Spain.
  • Jäger U; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Cartron G; Medical University of Vienna, Vienna, Austria.
  • Izutsu K; Montpellier University Hospital Center, UMR CNRS 5535, Montpellier, France.
  • Dreyling M; National Cancer Center Hospital, Tokyo, Japan.
  • Kahl B; LMU University Hospital, München, Germany.
  • Ghesquieres H; Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
  • Ardeshna K; Hôpital Lyon Sud, Lyon, France.
  • Goto H; University College London Hospitals Biomedical Research Centre, London, UK.
  • Barbui AM; Hokkaido University Hospital, Sapporo, Japan.
  • Abramson JS; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
  • Borchmann P; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Fleury I; Universität zu Köln, Köln, Germany.
  • Mielke S; Hôpital Maisonneuve - Rosemont, Montreal, Quebec, Canada.
  • Skarbnik A; Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, Stockholm, Sweden.
  • de Vos S; Novant Health Cancer Institute, Charlotte, NC, USA.
  • Kamdar M; UCLA Santa Monica Medical Centre, Santa Monica, CA, USA.
  • Karmali R; University of Colorado Cancer Center, Aurora, CO, USA.
  • Viardot A; Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.
  • Farazi T; Department of Internal Medicine III, University Hospital, Ulm, Germany.
  • Fasan O; Bristol Myers Squibb, Brisbane, CA, USA.
  • Lymp J; Bristol Myers Squibb, Princeton, NJ, USA.
  • Vedal M; Bristol Myers Squibb, Seattle, WA, USA.
  • Nishii R; Bristol Myers Squibb, Seattle, WA, USA.
  • Avilion A; Bristol Myers Squibb, Princeton, NJ, USA.
  • Papuga J; Bristol Myers Squibb, Seattle, WA, USA.
  • Kumar J; Bristol Myers Squibb, Boudry, Switzerland.
  • Nastoupil LJ; Bristol Myers Squibb, Princeton, NJ, USA.
Nat Med ; 30(8): 2374, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38982297
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Francia